Cumberland Pharmaceuticals Return On Equity vs. Profit Margin

CPIX Stock  USD 5.19  0.32  6.57%   
Based on Cumberland Pharmaceuticals' profitability indicators, Cumberland Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Cumberland Pharmaceuticals' ability to earn profits and add value for shareholders.
 
Return On Equity  
First Reported
2010-12-31
Previous Quarter
(0.24)
Current Value
(0.23)
Quarterly Volatility
0.14504703
 
Credit Downgrade
 
Yuan Drop
 
Covid
Price To Sales Ratio is likely to drop to 0.71 in 2025. Days Sales Outstanding is likely to drop to 55.38 in 2025. Operating Income is likely to rise to about (5.3 M) in 2025. Income Before Tax is likely to rise to about (5.4 M) in 2025.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.940.97
Sufficiently Down
Pretty Stable
For Cumberland Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cumberland Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cumberland Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cumberland Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cumberland Pharmaceuticals over time as well as its relative position and ranking within its peers.
  

Cumberland Pharmaceuticals' Revenue Breakdown by Earning Segment

Check out Trending Equities.
For more information on how to buy Cumberland Stock please use our How to Invest in Cumberland Pharmaceuticals guide.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cumberland Pharmaceuticals. If investors know Cumberland will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cumberland Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.76)
Revenue Per Share
2.607
Quarterly Revenue Growth
(0.1)
Return On Assets
(0.06)
Return On Equity
(0.36)
The market value of Cumberland Pharmaceuticals is measured differently than its book value, which is the value of Cumberland that is recorded on the company's balance sheet. Investors also form their own opinion of Cumberland Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Cumberland Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cumberland Pharmaceuticals' market value can be influenced by many factors that don't directly affect Cumberland Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cumberland Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cumberland Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cumberland Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cumberland Pharmaceuticals Profit Margin vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cumberland Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Cumberland Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Cumberland Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in profit margin category among its peers . At this time, Cumberland Pharmaceuticals' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cumberland Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Cumberland Profit Margin vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Cumberland Pharmaceuticals

Return On Equity

 = 

Net Income

Total Equity

 = 
-0.36
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Cumberland Pharmaceuticals

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.30) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.

Cumberland Profit Margin Comparison

Cumberland Pharmaceuticals is currently under evaluation in profit margin category among its peers.

Cumberland Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cumberland Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cumberland Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Cumberland Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Cumberland Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Operating Income-5.6 M-5.3 M
Income Before Tax-5.7 M-5.4 M
Total Other Income Expense Net-85.3 K-81 K
Net Loss-5.7 M-5.4 M
Income Tax Expense41.2 K39.1 K
Net Loss-5 M-4.8 M
Net Loss-2.2 M-2.4 M
Non Operating Income Net Other86.6 K82.3 K
Interest Income226.4 K168.8 K
Net Interest Income-375.3 K-356.5 K
Change To Netincome-2 M-1.9 M
Net Loss(0.51)(0.48)
Income Quality(1.12)(1.06)
Net Income Per E B T 1.15  1.11 

Cumberland Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cumberland Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cumberland Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cumberland Pharmaceuticals' important profitability drivers and their relationship over time.

Learn to be your own money manager

Our tools can tell you how much better you can do entering a position in Cumberland Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Use Investing Themes to Complement your Cumberland Pharmaceuticals position

In addition to having Cumberland Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Cumberland Stock Analysis

When running Cumberland Pharmaceuticals' price analysis, check to measure Cumberland Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cumberland Pharmaceuticals is operating at the current time. Most of Cumberland Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cumberland Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cumberland Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cumberland Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.